PSMA-1092

N/A

Report date: 2022/01/05 15:24:33
NME

Base Information

Drug NamePSMA-1092
Drug Alias NamePSMA-1092
ClassificationDiagnostic agent (In vivo)
Mechanisms of ActionAnti-PSMA
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsContrast agentsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Normal University
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsContrast agentsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A